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DIETARY SUPPLEMENTS IN MULTIPLE SCLEROSIS
A. Alajbegović, S. Alajbegović, J. Đelilović-Vranić
Neurology Clinic - University Clinical Center Sarajevo, Bosnia and Herzegovina
SUMMARY – Replacement therapy is a treatment that is not based on accepted medical knowl-
edge and science that is not in accordance with current medical doctrine.
Additional treatment is not contrary to the accepted doctrine of medical schools, but serves only 
as a supplement to the accepted treatment. Most general practitioners in England and Germany do 
not contradict these forms of treatment. On average 2/3 of patients with MS in the course of the 
disease try alternate options and additional treatment.
Alternate forms of treatment that are most commonly used are: diet, homeopathy, chiropractic 
procedures and methods of relaxation
Detrimental eff ects of alternative and complementary treatments for patients with MS is not 
known, but we must avoid the use of active substances entering the body and blood of patients, be-
cause in that way we can start a modifi ed immune response. Used are acupuncture, and particularly 
yoga. Cannabis takes special place. Cannabinoids have antioxidant and neuroprotective eff ect. Oral 
cannabinoids and marijuana smoking can relieve some symptoms of MS including spasm and pain. 
Th e controlled studies did not validate the eff ect of oral cannabinoids on spasm in MS.
Th e aim is to give a brief overview of dietary supplements and the eff ects of certain vitamins, 
minerals and oil in people with multiple sclerosis.
Replacement therapy is a treatment that is not 
based on accepted medical knowledge and science that 
is not in accordance with current medical doctrine.
Additional treatment is not contrary to the ac-
cepted doctrine of medical schools, but serves only 
as a supplement to the accepted treatment. Most 
general practitioners in England and Germany do 
not contradict these forms of treatment. On average 
2/3 of patients with MS in the course of the disease 
try alternate options and additional treatment. Th is 
treatment is used primarily by groups of older, well-
educated patients with higher impairment, in whom 
the disease lasts longer. Alternate forms of treatment 
that are most commonly used are: diet, homeopathy, 
chiropractic procedures and methods of relaxation. 
Most patients are keen on these forms of treatment 
on the initiative of friends and acquaintances, mostly 
in the progressive stage. Most of the patients choose 
on their own these treatments without the knowledge 
of physicians, which in most cases result from fear of 
possible negative attitude of doctors. It is good that 
doctors carefully listen to the proposal of patients 
about “diff erent” treatment that is not harmful. It 
is recommended that physicians have at least a clear 
knowledge about other possible forms of treatment. 
We must be aware that patients typically report a sat-
isfactory transient eff ect of diff erent methods.
Detrimental eff ects of alternative and complemen-
tary treatments for patients with MS is not known, 
but we must avoid the use of active substances enter-
ing the body and blood of patients, because in that 
way we can start a modifi ed immune response.
Echinacea, which is commonly used plant extracts 
to improve the defense capabilities of the body, is not 
recommended in patients with MS, although there 
is no reliable data on the increasing number of epi-
sodes.
Also are not recommended any ozone inhalations 
and transfusion of their own blood as auto transfu-
sion. Possible sensitization may initiate formation of 
toxic substances that are harmful to the course of dis-
ease.
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Q10 refreshes the immune system, which is in MS 
patients impaired.
Almost one fi fth of patients during long-term 
treatment tested effi  cacy of acupuncture. With acu-
puncture we infl uence the pain, diffi  culties in urina-
tion and psychological tension. Studies were conduct-
ed on the eff ect of acupuncture only in small groups of 
patients, which is insuffi  cient for a reliable assessment 
of its effi  cacy.
Th ai-chi has been recognized in some countries 
as an additional method of treatment. Th is method 
fosters harmony and inner strength. In China it is rec-
ognized as the prevention of this disease. Th e reports 
indicated that this method contributes to a safer walk-
ing, reduces excessive muscle tension and fatigue, and 
has an impact on mood and composure.
Yoga was developed in India, and now is taught in 
accordance with the needs of man. Yoga stretches the 
muscles and has a special way of breathing. Regular 
practicing yoga can infl uence synchronization of in-
ternal organs that are associated with the proper op-
eration of the CNS. Reports speak about the benefi -
cial eff ects of yoga on pain, fatigue, muscle stiff ness, 
mobility of joints and spine, as well as a better mood.
Cannabis
Cannabinoids have antioxidant and neuroprotec-
tive eff ect. Oral cannabinoids and marijuana smoking 
can relieve some symptoms of MS including spasm 
and pain. Th e controlled studies did not validate the 
eff ect of oral cannabinoids on spasm in MS.
Use of marijuana can have a variety of side eff ects 
such as sedation, diffi  cult driving, and when smoking 
cancer and respiratory diseases.
From every substance that we use is expected to 
slow disease progression, reduce the unpleasant symp-
toms, have no side eff ects and that is not too expen-
sive.
Th e use of cannabis is after tobacco smoking and 
alcohol drinking the most common bad habit. Can-
nabis is a psychoactive substance that causes a slight 
change in psychomotor and cognitive activity. Rarely 
it have the unpleasant eff ects in the form of anxiety, 
hallucinations and lewd. It can cause ecstasy - calm-
ness, rapid heartbeat, decreased blood pressure, in-
creased appetite, dry mouth and dizziness. Th rough 
surveys conducted in Canada, US and England it was 
found that the prevalence of cannabis use in patients 
with MS is not so small, and that 14-16% of them had 
used cannabis.
Patients reported reduction of pain that came as a 
result of impaired activity of CNS and that is both-
ered by illness, then to reduce muscle tension, diffi  -
culty in urination, stress, improving sleep and mood, 
and reduce cramps and muscle pain. Some patients 
have described the improvement of balance, gait and 
sexual activity. Shivering is not objectively reduced, 
although the patients reported that they personally 
feel better. Experiences with cannabis had primarily 
young men, smokers and patients who are already be-
fore the disease for the purpose of entertainment oc-
casionally used cannabis. Objective improvement was 
not convincing.
In the Netherlands since 2003 is allowed to use 
cannabis for medical purposes, and doctors can pre-
scribe it. Active substance MGC (medical-grade can-
nabis) is prescribed primarily to patients with MS, 
severe brain and spinal cord injuries, diffi  culties with 
muscles and bones, cancer, weight loss and pain. Th e 
eff ect was better after inhalation than after taking the 
pills.
Preparations as Marinol, Sativex Cannador also 
containing cannabis.
Results of treatment with cannabis are encourag-
ing, although caution is advisable in particular due to 
brain-blood vessels events.
ALOA VERA has a laxative eff ect and is useful in 
patients with constipation.
Indian ginseng (American, Ashwagandha) could 
theoretically pose a risk in MS and interfere with the 
eff ects of immunomodulating and immunosuppressive 
therapy. It has sedative properties that may aggravate 
fatigue and enhance the sedative eff ect of treatment.
ASIAN GINSENG (Chinese, Japanese) accord-
ing to limited data the plant moderately improves 
cognitive function and prevent common colds and fl u. 
It was never explored its use in cognitive dysfunction 
in MS.
SIBERIAN GINSENG (Eleutherococcus senti-
cosus, Eleuthera, Eleuthero) is diff erent from Ameri-
can and Asian ginseng and contains eleuterozide 
which may have antioxidant, anticarcinogenic and 
antiagregant eff ect. It is claimed that is eff ective for 
fatigue and many other states but that is not clinically 
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proven. In fact, Siberian ginseng can cause sedation, 
which exacerbates fatigue in MS or enhances the ef-
fect of sedative drugs.
GINKGO BILOBA generally refers to the extract 
of Ginkgo biloba, herbal preparation that is obtained 
from the leaves of ginkgo tree. Th ere are preliminary 
evidences that ginkgo biloba extract improves cog-
nitive function in MS. Th ere aren’t confi rmations in 
clinical studies that the extract of ginkgo biloba is ef-
fective in the treatment of exacerbation.
NONI JUICE is made from the fruit of Morinda 
citrifolia plant. It is recommended as eff ective in MS, 
however, no published clinical studies exist on its use 
in MS.
PADMA 28 is a complex mixture of more than 20 
plants that is sometimes recommended for the treat-
ment of MS. Th ere seems it have immunosuppressive 
and antioxidant eff ect. New studies are needed to de-
termine the safety and effi  cacy of these mixtures.
REISHI MUSHROOM, known as “the elixir 
of life” is a component of traditional Chinese phyto-
therapy.
SAGE has sedative properties that may aggravate 
fatigue in MS or enhance sedative eff ects of the treat-
ment.
NETTLE has a benefi cial eff ect in urinary tract 
infections.
CHAMOMILE and CELERY have sedative 
properties that may help patients with MS.
CRANBERRY is probably eff ective in prevent-
ing urinary tract infections. Two chemical ingredient, 
proanthocyanidin and fructose, can lower adherence 
of bacteria in urinary tract epithelial cells. Fructose 
also has antibacterial properties. However, for the 
treatment of urinary tract infection should not be 
used because we have eff ective antibiotics as well as 
the complications that can arise with untreated uri-
nary tract infections, especially in patients with MS.
SASSAFRAS (a type of laurel) is recommended 
for infections and urinary tract disorders.
BELLADONA some patients like to take and 
have good eff ect as a calming agent.
SENA has laxative properties and is eff ective in 
treating constipation.
VALERIANA (Valeriana offi  cinalis) may be ef-
fective in treating insomnia. Sometimes recommend-
ed for treatment of depression, anxiety and spasms. It 
is usually well tolerated.
BEE PRODUCTS
BEE POLLEN – there is no data on its effi  cacy in 
MS. Rarely can cause severe reactions in people with 
pollen allergy, over sensitivity to the sting of a bee and 
a person with an allergy to honey.
PROPOLIS and other bee products are sometimes 
recommended for the treatment of MS, but there is no 
published studies on their use in MS. May have mild 
antibacterial and antiviral eff ect.
ROYAL JELLY is the milk secret by the pharyn-
geal glands of the young honey bees and is used for 
feeding the queen. It is sometimes recommended as 
an eff ective therapy in MS, but no data support it. But 
in people with asthma or allergies may cause aller-
gic symptoms, including pruritus, urticaria, eczema, 
conjunctivitis, rhinorrhea, dyspnea, face and eyelids 
swelling and asthma.
FATTY ACID
Polyunsaturated fatty acids (PFA) that were tested 
as supplements in MS include omega-3 and omega-6 
polyunsaturated fatty acids. Omega-6 fatty acids in-
clude linoleic and gamma-linolenic acid. Th ere are a lot 
of data that PFA may have therapeutic eff ect in MS. 
Many studies on PFA, especially omega-3, showed 
immunomodulatory eff ects, including decreased 
lymphocyte proliferation and reduced production of 
proinfl ammatory cytokines in lymphocytes.
More uncontrolled studies on PFA reported the 
clinical improvement of MS. In fi ve controlled trials 
of the use PFA in patients with relapsing-remitting 
MS has not shown the safety and tolerability of the 
application. Despite the lack of defi nitive data people 
with MS will sometimes consider the use of PFA as a 
reasonable attempt.
OILS
Black currant seed oil, borage seed oil, prim-
rose oil, fl axseed oil, saffl  ower seed, sunfl ower seed 
oil containing omega-6 polyunsaturated fatty acids. 
Flaxseed oil contains especially omega-3 polyunsatu-
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rated fatty acids. Using oil in some people reduced the 
number of relapses and reportedly slowed down the 
progression. Specifi ed oils have moderate immuno-
suppressive eff ect.
If polyunsaturated fatty acids are regularly added 
to the diet also should be taken vitamin E.
OIL FROM COD LIVER and FISH OIL con-
tain omega -3 polyunsaturated fatty acids. Th ese ac-
ids are found in fi sh oil and fatty fi sh such as salmon, 
mackerel, sardines, herring, and tuna. Omega 3 fatty 
acids are also recommended for patients and appar-
ently acting on immune process.
CAFFEINE AND PRODUCTS 
CONTAINING IT
CAFFEINE is available in tablets and is contained 
in the coff ee, tea, Coca-Cola, guarana. It is eff ective 
in improving alertness and intellectual agility, and by 
the statements of some MS patients reduce fatigue.
COFFEE contains caff eine. Th e content of caf-
feine in a cup of coff ee is 100-150mg for fi ltered coff ee, 
85-100mg for instant coff ee and 8mg for decaff einated 
coff ee. Caff eine is eff ective in reinforcing vigilance, 
and in some patients with MS on reducing fatigue. 
Th ere are no studies on the eff ects of caff eine or coff ee 
on fatigue, cognitive dysfunction or other symptoms 
of MS. A reasonable dose (2-3 cups of coff ee or 250-
300 mg of caff eine per day) is usually well tolerated. 
But caff eine diuretic and urinary tract irritation can 
exacerbate bladder problems associated with MS and 
use of caff eine increases the risk of osteoporosis.
COLA NUT has a similar eff ect as coff ee.
GUARANA, MATE, GREEN TEA contains 
caff eine and has similar eff ects as coff ee.
VITAMINS
VITAMIN D
Even before 30 years were published data on the 
role of vitamin D in patients with multiple sclerosis. 
In recent years interest in the role of vitamin D was 
increased and epidemiological studies have shown 
higher risk of developing multiple sclerosis in patients 
with reduced levels of vitamin D.
Th e primary form of vitamin D (vitamin D3) is 
created from two sources: skin exposure to sunlight 
and ultraviolet B rays and through the diet. Vitamin 
D3 is found in certain foods - milk, orange juice, 
cheeses, cereals, blue fi sh (salmon and tuna). It should 
be noted that most of the vitamin D is obtained by 
ultraviolet B rays during sun tanning.
Vitamin D acts on the regulation of calcium and 
also has an important eff ect on brain function and dif-
ferentiation of immune cells and modulatory eff ect of 
the immune process. As is well known from epide-
miological studies, vulnerability to multiple sclerosis 
is lower in regions with a high percentage of sunny 
days.
In many patients with multiple sclerosis, demon-
strated are decreased levels of vitamin D. Studies have 
also shown that in patients with exacerbation of the 
disease, the level of vitamin D was reduced relative to 
the stable phase of the disease. Some have even found 
that the deterioration in patients was associated with 
the months when the level of vitamin D was the low-
est. It also describes the eff ect of vitamin D on cog-
nitive abilities. Based on this more is manifested the 
role of vitamin D in the prevention of diseases such 
as multiple sclerosis. Th ere are strong indications that 
vitamin D in early adolescence and early adulthood 
has a strong infl uence on the possibility of diseases 
such as multiple sclerosis.
Vitamin A (axerophtol) belongs to a group of 
structurally related molecules known as retinoids. Be-
ta-carotene and vitamin A has many biological eff ects 
including antioxidant and immune activity.
Vitamin B1 (thiamin, aneurin) is sometimes rec-
ommended for treating fatigue.
Vitamin B2 (ribofl avin), B3 (niacin), B6 (pyridox-
ine) and B9 (folic acid) do not have clear applications 
in MS.
Vitamin B12 (cyanocobalamin) is sometimes rec-
ommended for MS. Th e smaller proportion of people 
with MS may have a lack of vitamin B12, and they 
may have the benefi t. Th ere is no proven data that it is 
useful to provide vitamin B12 to MS patients who do 
not have its lack.
Vitamin C (Acidum ascorbicum) is sometimes 
recommended for several reasons. First, patients with 
MS may to some extent reduce the duration of colds 
and thus secondarily reduce the risk of worsening of 
the disease. Vitamin C has the antioxidant properties. 
Th ere is considerable data indicating that the oxidative 
damage induced by free radicals increased in patients 
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with MS and harmful oxidative processes involved in 
myelin damage and nerve extensions.
Vitamin E (tocopherol) is recommended in the MS 
due to its antioxidant properties. Vitamin E is impor-
tant for people who have a diet with unsaturated fatty 
acids.
Hyperbaric Chamber
Th ere have been attempts of treatment with hyper-
baric chamber, where the patient breathes oxygen at 
high pressure. Benefi cial eff ect was found in a survey 
treatment of the signs at the artifi cially induced al-
lergic infl ammation of the brain. Th e eff ect in patients 
with MS is questionable - since 1983 seven researches 
were carried out. None proved reliable eff ect in pa-
tients with MS. Today we have a hyperbaric chamber 
in Bosnia and Herzegovina. Treatment in a hyperbar-
ic chamber has been successful primarily in the treat-
ment of gas gangrene and extensive burns.
Diet
Among Norwegian fi shermen there is less MS 
than among Norwegian farmers, and the cause most 
likely lies in the fact that farmers use large amounts of 
animal fat. It is possible that the fats that are rich in 
saturated fatty acids reduce the formation of myelin 
in the brain.
Described are the various types of diets. Th ere are 
confl icting reports about the eff ect of linoleic acid 
(an unsaturated fatty acid) and its products of these 
acids (prostaglandins), which act preventively on the 
immune system. Eating foods that are less industri-
ally processed (Evers diet), diet with low fat and al-
tered ratio of omega 3 and omega-6 supplemented 
with selenium, fi sh oil, coenzymes Q (Fratzer diet) 
and reducing diet with unsaturated fatty acids with 
the addition of limited amounts of vegetable and fi sh 
oils (Swank diet) was not associated with reliable im-
provement of disease.
Some recommend restriction of gluten in the diet 
(grains).
Smoking is not recommended. Th ere is a moderate 
relationship between smoking and MS. Infl uence of 
organic solvents has not been proven.
